News
HOOKIPA Pharma Inc. (NASDAQ: HOOK, “HOOKIPA”), a clinical-stage biopharmaceutical company developing next-generation immunotherapeutics for the treatment of cancer and serious infectious diseases, ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback